Akebia Therapeutics (AKBA) just unveiled an announcement.
Erik Ostrowski has been appointed as the Senior Vice President, CFO, CBO, Treasurer, and principal financial officer of Akebia Therapeutics, Inc., effective June 24, 2024. He brings extensive experience from previous roles at AVROBIO, Inc. and Summit Therapeutics plc. His compensation includes a $540,000 base salary, up to a 45% bonus, stock options for 500,000 shares, and 350,000 restricted stock units. Ostrowski’s financial expertise, honed at prestigious institutions and companies, promises to be a valuable asset to Akebia Therapeutics’ executive team.
For an in-depth examination of AKBA stock, go to TipRanks’ Stock Analysis page.
